Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC
Clinical Companion: The Role of Immunotherapy in Advancing the Treatment of HCC and BTC
Addressing the Unmet Needs of Myotonic Dystrophy Type 1 (DM1)
Webinar | 0.75 - 45 mins | Interactive Case | Rheumatology | Biosimilars | BiosimilarsCME.org | Online |
A ACCME Accredited provider.
The France Foundation ©
Chandler Building, 84 Lyme Street, Old Lyme, CT USA